Do recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma?
Recurrent Ig translocations identify at least three distinct molecular subtypes of myeloma. Our long-term goal is to determine if there are phenotypic, prognostic and therapeutic differences associated with these molecular subtypes.
I/R produced a significant upregulation of ICAM-1 expression which correlated with impaired flow in the HM.